FrancophonIA/ELRC3.0 huggingface dataset:
English: Additionally, some patients developed recall injection site reactions characterised by a skin reaction at the most recent site of injection along with the simultaneous appearance of injection site reactions at previous injection sites.
Croatian: Naknadno se u nekih bolesnika ponovno pojavila reakcija na mjestu primjene injekcije karakterizirana reakcijom kože na najsvježijem mjestu primjene, uz istodobnu pojavu reakcije na prethodnim mjestima primjene injekcije.
English: Studies have not been done in patients with juvenile idiopathic arthritis to assess the effects of continued LIFMIOR therapy in patients who do not respond within 3 months of initiating LIFMIOR therapy.
Croatian: U bolesnika s juvenilnim idiopatskim artritisom nisu provedena ispitivanja učinaka kontinuirane terapije LIFMIORom u onih koji nisu odgovorili u roku od 3 mjeseca nakon početka terapije LIFMIORom.
English: • Signs of heart failure or worsening heart failure, such as fatigue or shortness of breath with activity, swelling in the ankles, a feeling of fullness in the neck or abdomen, night-time shortness of breath or coughing, bluish colour of the nails or the lips
Croatian: • Znakovi zatajenja srca ili pogoršanja zatajenja srca, kao što su umor ili nedostatak zraka prilikom aktivnosti, oticanje gležnjeva, osjećaj punoće u vratu ili trbuhu, nedostatak zraka ili kašalj tijekom noći, modra boja noktiju ili usana.
English: Month 6
Croatian: 6. mjesec
English: Reports have included fatal and life-threatening infections and sepsis.
Croatian: Prijave uključuju slučajeve fatalnih i životno ugrožavajućih infekcija i sepse.
English: Your doctor will decide how long you should take LIFMIOR and whether retreatment is needed based on your response.
Croatian: Na temelju Vašeg odgovora na liječenje liječnik će odlučiti koliko dugo trebate primjenjivati LIFMIOR i je li potrebno ponoviti liječenje.
English: In lactating rats following subcutaneous administration, etanercept was excreted in the milk and detected in the serum of pups.
Croatian: Za vrijeme laktacije u ženki štakora, nakon supkutane primjene, etanercept se izlučio u mlijeku te je otkriven u serumu sisajuće mladunčadi.
English: Skin cancers
Croatian: Rak kože
English: LIFMIOR has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease.
Croatian: Pokazalo se da LIFMIOR dovodi do poboljšanja fizičke funkcije u bolesnika s psorijatičnim artritisom te da smanjuje brzinu napredovanja oštećenja perifernih zglobova određenu pomoću rendgena u bolesnika s poliartikularnom simetričnom podvrstom bolesti.
English: With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 3).
Croatian: Brzim, kratkim pokretom ubodite iglom kroz kožu pod kutom između 45° i 90° (vidjeti sliku 3).
English: The following instructions explain how to prepare and inject LIFMIOR.
Croatian: Sljedeće upute objašnjavaju način pripreme i primjene injekcija LIFMIORa.
English: Remove the needle cover by firmly pulling it straight off the syringe (see Diagram 2).
Croatian: Uklonite pokrov s igle tako što ćete ga čvrsto povući ravno sa štrcaljke (vidjeti sliku 2).
English: Tuberculosis, opportunistic infection (including invasive fungal, protozoal, bacterial, atypical mycobacterial, viral infections, and Legionella)*
Croatian: Tuberkuloza, oportunistička infekcija (uključujući invazivne gljivične, protozoalne, bakterijske, atipične mikobakterijske, virusne infekcije i Legionellu)*
English: The LIFMIOR solution should not be mixed with any other medicine before use.
Croatian: Otopinu LIFMIORa se ne smije miješati niti s jednim drugim lijekom prije primjene.
English: Tell your doctor if you or the child develop any change in the appearance of the skin or growths on the skin.
Croatian: Recite svom liječniku ako Vi ili dijete primijetite bilo kakve promjene u izgledu kože ili izrasline na koži.
English: The powder must be dissolved before use.
Croatian: Prije primjene prašak se mora otopiti.
English: Neurological disorders
Croatian: Neurološki poremećaji
English: • The risk of Congestive Heart Failure (CHF).
Croatian: • rizik od kongestivnog zatajenja srca.
English: Physicians should use caution when using LIFMIOR in patients who also have moderate to severe alcoholic hepatitis.
Croatian: Liječnici moraju biti oprezni kada primjenjuju LIFMIOR u bolesnika koji boluju od umjerenog do teškog alkoholnog hepatitisa.
English: In the toxicological studies with LIFMIOR, no dose-limiting or target organ toxicity was evident.
Croatian: U toksikološkim ispitivanjima LIFMIORa nije zabilježena toksičnost koja ograničava dozu, kao ni toksičnost prema ciljnim organima.
English: Preparing the LIFMIOR dose for injection
Croatian: Priprema doze LIFMIORa za injekciju
English: Adult patients treated with LIFMIOR and anakinra were observed to have a higher rate of serious infection when compared with patients treated with either LIFMIOR or anakinra alone (historical data).
Croatian: U odraslih bolesnika koji su istodobno liječeni LIFMIORom i anakinrom opažena je povećana stopa ozbiljnih infekcija u usporedbi s bolesnicima koji su liječeni samo LIFMIORom ili samo anakinrom (povijesni podaci).
English: Developmental toxicity studies performed in rats and rabbits have revealed no evidence of harm to the foetus or neonatal rat due to etanercept.
Croatian: Ispitivanja razvojne toksičnosti u štakora i kunića nisu pokazala nikakve štetne učinke etanercepta na fetus ni na novookoćene štakore.
English: • With the syringe still attached, gently move the vial in circles a few times, to dissolve the powder (see Diagram 9).
Croatian: • Dok je štrcaljka i dalje spojena, nježno kružnim pokretima zavrtite bočicu nekoliko puta kako bi se prašak otopio (vidjeti sliku 9).
English: The safety and efficacy profiles of the 50 mg once weekly and 25 mg twice weekly regimens were similar.
Croatian: Profili sigurnosti primjene i djelotvornosti režima od 50 mg jednom tjedno i 25 mg dva puta tjedno bili su slični.
English: The highest dose level evaluated has been an intravenous loading dose of 32 mg/m2 followed by subcutaneous doses of 16 mg/m2 administered twice weekly.
Croatian: Najviša ispitana udarna doza iznosila je 32 mg/m2 primijenjena intravenski nakon čega su slijedile supkutane doze od 16 mg/m2 primjenjivane dva puta tjedno.
English: Additionally, the pharmacokinetics of LIFMIOR in rheumatoid arthritis patients, ankylosing spondylitis and plaque psoriasis patients are similar.
Croatian: Nadalje, farmakokinetika LIFMIORa u bolesnika s reumatoidnim artritisom, ankilozantnim spondilitisom i plak psorijazom je slična.
English: Congestive heart failure (Cardiac failure congestive) Physicians should use caution when using LIFMIOR in patients who have congestive heart failure (CHF).
Croatian: Kongestivno zatajenje srca (Kongestivno srčano zatajenje) Liječnici moraju biti oprezni prilikom propisivanja LIFMIORa bolesnicima koji boluju od kongestivnog zatajenja srca.
English: LIFMIOR in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults when the response to disease-modifying antirheumatic drugs, including methotrexate (unless contraindicated), has been inadequate.
Croatian: LIFMIOR je u kombinaciji s metotreksatom indiciran za liječenje umjerenog do teškog aktivnog reumatoidnog artritisa u odraslih u slučaju neadekvatnog odgovora na antireumatske lijekove koji modificiraju tijek bolesti, uključivši metotreksat (osim ako je kontraindiciran).
English: • Trouble swallowing or breathing • Swelling of the face, throat, hands, or feet
Croatian: • Tegobe s gutanjem ili disanjem • Oticanje lica, grla, šaka ili stopala
English: In a group of 7,416 patients treated with LIFMIOR in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis clinical trials, 18 lymphomas were reported.
Croatian: U 7416 bolesnika liječenih LIFMIORom u kliničkim ispitivanjima reumatoidnog artritisa, psorijatičkog artritisa, ankilozantnog spondilitisa i psorijaze, zabilježeno je 18 limfoma.
English: In another observational multi-country registry study comparing the risk of adverse pregnancy outcomes in women exposed to etanercept during the first 90 days of pregnancy (n=425) to those exposed to non-biologic drugs (n=3497), there was no observed increased risk of major birth defects (crude odds ratio [OR]= 1.22, 95% CI: 0.79-1.90; adjusted OR = 0.96, 95% CI: 0.58-1.60 after adjusting for country, maternal disease, parity, maternal age and smoking in early pregnancy).
Croatian: U drugom opservacijskom ispitivanju u obliku registra, provedenom u više država, koje je uspoređivalo rizik od štetnih ishoda trudnoća u žena izloženih etanerceptu tijekom prvih 90 dana trudnoće (n=425) i žena izloženih nebiološkim lijekovima (n=3 497), nije zabilježen povećan rizik od velikih urođenih mana (grubi omjer izgleda = 1,22; 95% CI: 0,79-1,90; prilagođen omjer izgleda = 0,96; 95% CI: 0,58-1,60 nakon prilagodbe prema državi, bolesti majke, paritetu, dobi majke i pušenju u ranom stadiju trudnoće).
English: Do not mix the LIFMIOR solution with any other medicine.
Croatian: Nemojte miješati otopinu LIFMIORa niti s jednim drugim lijekom.
English: Elevated levels of TNF are also found in the synovium and psoriatic plaques of patients with psoriatic arthritis and in serum and synovial tissue of patients with ankylosing spondylitis.
Croatian: Povišene koncentracije TNF-a pronađene su također u sinoviji i psorijatičnim plakovima bolesnika sa psorijatičnim artritisom te u serumu i sinovijalnom tkivu bolesnika s ankilozantnim spondilitisom.
English: Patients in the LIFMIOR in combination with methotrexate therapy group had significantly higher ACR 20, ACR 50, ACR 70 responses and improvement for DAS and HAQ scores at both 24 and 52 weeks than patients in either of the single therapy groups (results shown in table below).
Croatian: Bolesnici liječeni kombinacijom LIFMIORa i metotreksata imali su značajno više ACR 20, ACR 50, ACR 70 odgovore i poboljšanje ocjena na ljestvici DAS i upitniku HAQ i u 24. i u 52. tjednu u odnosu na bolesnike u bilo kojoj od skupina s monoterapijom (rezultati su prikazani u sljedećoj tablici).
English: • Once the solvent is added to the LIFMIOR, the plunger may move up by itself.
Croatian: • Nakon dodavanja otapala lijeku LIFMIOR, klip se može sam povući prema gore.
English: Pre-filled pen (MYCLIC) containing a pre-filled syringe of LIFMIOR.
Croatian: Napunjena brizgalica (MYCLIC) koja sadrži napunjenu štrcaljku LIFMIORa.
English: Patients received LIFMIOR 0.8 mg/kg (up to 50 mg) or placebo once weekly for 12 weeks.
Croatian: Bolesnici su primali LIFMIOR 0,8 mg/kg (do 50 mg) ili placebo jednom tjedno tijekom 12 tjedana.
English: Do not use the pen if it is dropped with the needle cap off.
Croatian: Nemojte koristiti brizgalicu ako je pala s otvorenim zatvaračem igle.
English: There have been rare reports of patients, including rheumatoid factor positive patients, who have developed other autoantibodies in conjunction with a lupus-like syndrome or rashes that are compatible with subacute cutaneous lupus or discoid lupus by clinical presentation and biopsy.
Croatian: Rijetka su izvješća o bolesnicima, uključujući i bolesnike s pozitivnim reumatoidnim faktorom, u kojih su se razvila autoprotutijela vezana uz sindrom sličan lupusu ili osipi koji kliničkom slikom i nalazom biopsije odgovaraju subakutnom kutanom ili diskoidnom lupusu.
English: Treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate.
Croatian: Liječenje aktivnog i progresivnog psorijatičnog artritisa u odraslih u slučaju prethodnog neadekvatnog odgovora na terapiju antireumatskim lijekovima koji modificiraju tijek bolesti.
English: Interstitial lung disease
Croatian: Intersticijska plućna bolest
English: The study evaluated 234 adult patients with active rheumatoid arthritis who had failed therapy with at least one but no more than four disease-modifying antirheumatic drugs (DMARDs).
Croatian: Ispitivanje je obuhvatilo 234 odrasla bolesnika s aktivnim reumatoidnim artritisom u kojih se nedjelotvornim pokazalo liječenje najmanje jednim, a najviše četirima antireumatskim lijekovima koji modificiraju tijek bolesti (DMARD).
English: All patients should be informed to seek medical advice if signs/symptoms suggestive of tuberculosis (e.g., persistent cough, wasting/weight loss, low-grade fever) appear during or after LIFMIOR treatment.
Croatian: Svim bolesnicima treba savjetovati da potraže liječnički savjet u slučaju pojave znakova/simptoma koji upućuju na tuberkulozu (npr. stalni kašalj, mršavljenje/gubitak tjelesne težine, subfebrilnost) za vrijeme ili nakon liječenja LIFMIORom.
English: A placebo-controlled trial, in which 89 adult patients were treated with LIFMIOR in addition to standard therapy (including cyclophosphamide or methotrexate, and glucocorticoids) for a median duration of 25 months, has not shown LIFMIOR to be an effective treatment for Wegener's granulomatosis.
Croatian: Placebom kontrolirano ispitivanje u kojem je 89 odraslih bolesnika liječeno LIFMIORom koji je dodan standardnoj terapiji (koja je uključivala ciklofosfamid ili metotreksat te glukokortikoide) s medijanom trajanja od 25 mjeseci nije pokazalo da je LIFMIOR učinkovit u liječenju Wegenerove granulomatoze.
English: Non-melanoma skin cancers* (see section 4.4)
Croatian: Ne-melanomski rak kože* (vidjeti dio
English: For patients who received 25 mg twice weekly throughout the study, the PASI 75 response continued to improve between weeks 12 and 36.
Croatian: U bolesnika koji su primali 25 mg dva puta tjedno kroz cijelo ispitivanje PASI 75 odgovor nastavio se poboljšavati između 12. i 36. tjedna.
English: The primary measure of efficacy (ASAS 20) was a ≥20% improvement in at least 3 of the 4 Assessment in Ankylosing Spondylitis (ASAS) domains (patient global assessments, back pain, BASFI, and inflammation) and absence of deterioration in the remaining domain.
Croatian: Primarna mjera djelotvornosti (ASAS 20) bila je  20%-tno poboljšanje u najmanje 3 od 4 parametra procjene ankilozantnog spondilitisa (Assessment in Ankylosing Spondylitis (ASAS)) (opća procjena bolesnika, bol u leđima, BASFI i upala) te odsutnost pogoršanja preostalog parametra.
English: The presence of hepatic impairment should not require a change in dosage.
Croatian: Prisutnost oštećenja bubrega ne bi trebala zahtijevati promjenu doziranja.
English: The percentage of patients who developed new positive anti-double-stranded DNA antibodies was also higher by radioimmunoassay (15% of patients treated with LIFMIOR compared to 4% of placebo-treated patients) and by Crithidia luciliae assay (3% of patients treated with LIFMIOR compared to none of placebo-treated patients).
Croatian: Postotak bolesnika koji su postali pozitivni na protutijela protiv dvostruke uzvojnice DNK bio je viši i pri određivanju protutijela radioimunoesejem (15% bolesnika koji su primali LIFMIOR u usporedbi s 4% bolesnika koji su primali placebo) i testom s Crithidia luciliae (3% bolesnika koji su primali LIFMIOR u usporedbi s 0% onih koji su primali placebo).
English: In an open-label, safety extension study, 58 paediatric patients from the above study (from the age of 4 years at time of enrolment) continued to receive LIFMIOR for up to 10 years.
Croatian: U otvorenom produžetku ispitivanja sigurnosti primjene 58 pedijatrijskih bolesnika iz gore opisanog ispitivanja (u dobi od 4 ili više godina u vrijeme uključenja) nastavilo je primati LIFMIOR do 10 godina.
English: Be careful not to bend or twist the cover during removal to avoid damage to the needle.
Croatian: Pazite da ne savijate pokrov dok ga uklanjate da se ne ošteti igla.
English: The 10 mg presentation is for paediatric patients prescribed a dose of 10 mg or less.
Croatian: Ovaj oblik lijeka od 10 mg namijenjen je pedijatrijskim bolesnicima kojima je propisana doza od 10 mg ili manja.
English: The proportion of subjects who developed antibodies to etanercept in longer-term trials (of up to 3.5 years) increases over time, as expected.
Croatian: Kao što je očekivano, udio bolesnika koji su razvili protutijela na etanercept u dugoročnim ispitivanjima (do 3,5 godine) povećava se vremenom.
English: The types and proportion of adverse events in juvenile idiopathic arthritis patients were similar to those seen in trials of LIFMIOR in adult patients with rheumatoid arthritis, and the majority were mild.
Croatian: Vrsta i udio štetnih događaja u bolesnika s juvenilnim idiopatskim artritisom bili su slični onima zabilježenim u ispitivanjima LIFMIORa u odraslih bolesnika s reumatoidnim artritisom i uglavnom blagi.
English: In the double-blind period, patients received LIFMIOR 50 mg weekly or placebo for 12 weeks.
Croatian: U dvostruko slijepom razdoblju bolesnici su primali LIFMIOR 50 mg tjedno ili placebo tijekom 12 tjedana.
English: Efficacy Response in Placebo-Controlled nr-AxSpa Study: Percent of Patients Achieving Endpoints
Croatian: Odgovor djelotvornosti u placebom kontroliranom ispitivanju nr-AxSpa: Postotak bolesnika koji su postigli mjere ishoda
English: A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČI BIOLOŠKE DJELATNE TVARI I PROIZVOĐAČI ODGOVORNI ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: The most commonly reported adverse reactions are injection site reactions (such as pain, swelling, itching, reddening and bleeding at the puncture site), infections (such as upper respiratory infections, bronchitis, bladder infections and skin infections), allergic reactions, development of autoantibodies, itching, and fever.
Croatian: Najčešće prijavljene nuspojave su reakcije na mjestu primjene injekcije (kao bol, oticanje, svrbež, crvenilo i krvarenje na mjestu uboda), infekcije (kao infekcije gornjih dišnih puteva, bronhitis, infekcije mokraćnog mjehura i kožne infekcije), alergijske reakcije, razvoj autoprotutijela, svrbež i vrućica.
English: There have been reports of hypoglycaemia following initiation of LIFMIOR in patients receiving medication for diabetes, necessitating a reduction in anti-diabetic medication in some of these patients.
Croatian: U bolesnika koji uzimaju lijekove za liječenje šećerne bolesti, nakon uvođenja LIFMIORa bila je zabilježena hipoglikemija, koja je zahtijevala smanjenje antidijabetika u nekih od tih bolesnika.
English: LIFMIOR is administered by an injection under the skin (by subcutaneous injection).
Croatian: LIFMIOR se daje injekcijom pod kožu (supkutanom injekcijom).
English: Eligible patients had a history of receiving phototherapy or systemic therapy, or were inadequately controlled on topical therapy.
Croatian: Bolesnici koji su udovoljavali uvjetima prethodno su primali fototerapiju ili sistemsku terapiju ili u njih nije uspostavljena odgovarajuća kontrola pri primjeni topikalne terapije.
English: You or the child should not use LIFMIOR with medicines that contain the active substance anakinra or abatacept.
Croatian: Niti Vi ni dijete ne biste smjeli primjenjivati LIFMIOR s lijekovima koji sadrže anakinru ili abatacept kao djelatnu tvar.
English: LIFMIOR treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of juvenile idiopathic arthritis or paediatric plaque psoriasis.
Croatian: Liječenje LIFMIORom treba započeti i nadzirati liječnik specijalist s iskustvom u dijagnostici i liječenju juvenilnog idiopatskog artritia ili plak psorijaze dječje dobi.
English: After the 12-week double-blind treatment period, all patients received LIFMIOR 0.8 mg/kg (up to 50 mg) once weekly for additional 24 weeks.
Croatian: Nakon dvostruko slijepog razdoblja liječenja u trajanju od 12 tjedana svi bolesnici dobivali su LIFMIOR 0,8 mg/kg (do 50 mg) jednom tjedno u trajanju od dodatna 24 tjedna.
English: The safety and efficacy of LIFMIOR in patients with chronic infections have not been evaluated.
Croatian: Nije procijenjena djelotvornost i sigurnost primjene LIFMIORa u bolesnika s kroničnom infekcijom.
English: Study 1 was a Phase 2 study in patients with active but clinically stable plaque psoriasis involving ≥ 10% of the body surface area that were ≥ 18 years old.
Croatian: Ispitivanje 1 bilo je ispitivanje faze II u koje su uključeni bolesnici s aktivnom, ali klinički stabilnom plak psorijazom koja zahvaća 10% površine tijela u dobi od 18 godina.
English: Concurrent treatment with sulfasalazine
Croatian: Istodobno liječenje sulfasalazinom
English: Please tell your doctor if the child in your care has a history of alcohol abuse.
Croatian: Recite svom liječniku ako dijete o kojem skrbite ima u anamnezi alkoholizam.
English: Caution should be exercised when administering LIFMIOR in patients previously infected with HBV.
Croatian: Nužan je oprez u slučaju davanja LIFMIORa bolesnicima koji su prethodno bili zaraženi HBV-om.
English: • Latex: The needle cover is made from latex (dry natural rubber).
Croatian: • Lateks: pokrov igle napravljen je od lateksa (suhe prirodne gume).
English: Step 1: Setting up for an injection
Croatian: Korak 1: Priprema za injekciju
English: • The three recommended injection sites for LIFMIOR include: (1) the front of the middle thighs; (2) the abdomen, except for the 5 cm area right around the navel; and (3) the outer area of the upper arms (see Diagram 17).
Croatian: • Tri preporučena mjesta za injekciju za LIFMIOR uključuju: (1) prednju stranu sredine natkoljenice; (2) trbuh, s iznimkom područja u krugu 5 cm oko pupka; te (3) vanjsku stranu nadlaktice (vidjeti sliku 17).
English: Patients weighing less than 62.5 kg should be accurately dosed on a mg/kg basis using the powder and solvent for solution for injection presentations or the powder for solution for injection presentations (see below for dosing for specific indication).
Croatian: Bolesnici tjelesne težine manje od 62,5 kg trebaju primiti točnu dozu u mg/kg pripremljenu pomoću praška i otapala za otopinu za injekciju ili praška za otopinu za injekciju (vidjeti niže za doziranje kod određene indikacije).
English: No studies on the effects on the ability to drive and use machines have been performed.
Croatian: Ispitivanja o utjecaju na sposobnost upravljanja vozilima i rada sa strojevima nisu provedena.
English: If you have questions about how to inject, please ask your doctor or nurse for help.
Croatian: Ako imate pitanja vezana uz način injiciranja, obratite se liječniku ili medicinskoj sestri za pomoć.
English: LIFMIOR treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, plaque psoriasis or paediatric plaque psoriasis.
Croatian: Liječenje LIFMIORom treba započeti i nadzirati liječnik specijalist s iskustvom u dijagnostici i liječenju reumatoidnog artritisa, juvenilnog idiopatskog artritisa, psorijatičnog artritisa, ankilozantnog spondilitisa, aksijalnog spondiloartrtitisa bez radiološkog dokaza, plak psorijaze ili plak psorijaze dječje dobi.
English: Etanercept is a dimer of a chimeric protein genetically engineered by fusing the extracellular ligand binding domain of human tumour necrosis factor receptor-2 (TNFR2/p75) to the Fc domain of human IgG1.
Croatian: Etanercept je dimer kimeričkog proteina koji se dobiva genetičkim inženjerstvom - fuzijom ekstracelularne domene receptora-2 ljudskog čimbenika nekroze tumora za ligande (TNFR2/p75) s Fc domenom ljudskog IgG1.
English: Etanercept is a human tumour necrosis factor receptor p75 Fc fusion protein produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian expression system.
Croatian: Etanercept je fuzijski protein kojeg čine Fc fragment i p75 receptor ljudskog čimbenika nekroze tumora (TNF) koji se proizvodi tehnologijom rekombinantne DNK u ekspresijskom sustavu stanica sisavaca iz jajnika kineskog hrčka (engl.